Product Overview
[Drug Name]
Trade Name: Visuolone
English Name: Irsogladine Maleate Tablets
Chinese Pinyin: Malaisuan Yisuolading Pian
[Ingredients]
The main ingredient of this product is irsogladine maleate. Its chemical name is 2,4-diamino-6-(2,5-dichlorophenyl)-1,3,5-triazine maleate. Molecular formula: C9H7Cl2N5·C4H4O4, Molecular Weight: 372.17
[Properties]
This product is a white or off-white tablet.
[Indications]
Gastric ulcer, relief of acute and chronic gastritis, and acute gastric mucosal lesions (erosion, bleeding, redness, edema).
[Dosage and Administration]
Oral administration: 4 mg daily, divided into 1-2 doses. The dosage may be adjusted appropriately based on age and symptoms.
[Adverse Reactions]
Occasionally, dizziness, nausea, vomiting, constipation, diarrhea, rash, loss of appetite, upper abdominal discomfort, and occasionally mild, reversible elevations in aminotransferase levels may occur.
[Contraindications]
Not yet known.
[Precautions]
1. If a rash occurs, discontinue the drug.
2. Elderly patients should start with a low dose (2 mg/day) and adjust the dose appropriately based on the response. 3. The use of this drug in pregnant and lactating women is not yet clear.
[Use in Special Populations]
Precautions for Children:
The safety of this drug in children has not been established (due to limited experience), so its use in children is not recommended.
Precautions for Pregnancy and Lactation:
Safety data are lacking during pregnancy and lactation. Therefore, this drug should be used only when the benefits outweigh the risks in pregnant women, women who may become pregnant, and lactating women.
Precautions for Elderly Patients:
Elderly patients have reduced physiological function, so the drug should be started with a low dose (e.g., 2 mg/kg/day), adjusted according to the patient's condition and tolerance, and used with caution.
[Drug Interactions]
Not yet known.
[Pharmacological Actions]
This product is a gastric mucosal protective agent. It strengthens the intercellular bonds of gastric mucosal epithelial cells, inhibits epithelial cell desquamation and shedding, and widens intercellular spaces, thereby enhancing the stability of the mucosal cells themselves. This protects the mucosa and inhibits the permeation of harmful substances through the mucosa. Its mechanism of action is related to increasing the levels of cAMP, prostaglandins, reduced glutathione, and mucus glycoproteins in gastric mucosal cells. Experimental studies have shown that this product can inhibit hydrochloric acid- and ethanol-induced gastric mucosal cell damage and increase gastric mucosal blood flow. The effect is dose-dependent.
[Storage]
Store tightly closed in a dry place.
[Strength]
2 mg
[Packaging]
2 mg x 24s/box
[Expiry Date]
24 months
[Approval Number]
National Medicine Standard No. H20050944
[Manufacturer]
Company Name: Shanghai Tianlong Pharmaceutical Co., Ltd.
